COST-EFFECTIVE STRATEGIES FOR THE FOLLOW-UP OF PATIENTS WITH GERM CELL TUMORS
- 1 August 1998
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 25 (3) , 495-502
- https://doi.org/10.1016/s0094-0143(05)70039-2
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Secondary malignancy among seminoma patients treated with adjuvant radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1995
- Cost and risk benefit in the management of clinical stage II nonseminomatous testicular tumorsCancer, 1995
- Late relapse of testicular cancer.Journal of Clinical Oncology, 1995
- Outcome analysis after post-chemotherapy surgery in patients with non-seminomatous germ cell tumoursAnnals of Oncology, 1995
- Efficacy of radiographic chest imaging inpatients with testicular cancerUrology, 1994
- Evolution and controversies in the management of low-stage nonseminomatous germ-cell tumors of the testisWorld Journal of Urology, 1994
- Primary Chemotherapy for Stage II Nonseminomatous Germ Cell Tumors of the TestisJournal of Urology, 1994
- HISTOPATHOLOGY IN THE PREDICTION OF RELAPSE OF PATIENTS WITH STAGE I TESTICULAR TERATOMA TREATED BY ORCHIDECTOMY ALONEThe Lancet, 1987
- Surveillance Alone for Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors of the Testis: Preliminary ResultsJournal of Urology, 1984
- ORCHIDECTOMY ALONE IN TESTICULAR STAGE I NON-SEMINOMATOUS GERM-CELL TUMOURSThe Lancet, 1982